1. |
Ruetten H, Southan GJ, Abate A, et al. Attenuation of endotoxininduced multiple organ dysfunction by 1amino2hydroxyguanidine, a potent inhibitor of inducible nitric oxide synthase [J]. Br J Pharmacol, 1996; 118(2)∶261.
|
2. |
Witte K, Schnecko A, Zuther P, et al. Contribution of the nitric oxideguanylyl cyclase system to circadian regulation of blood pressure in normotensive WistarKyoto rats [J]. Cardiovasc Res, 1995; 30(5)∶682.
|
3. |
Yang F, Comtois AS, Fang L, et al. Nitric oxidederived nitrate anion contributes to endotoxic shock and multiple organ injury/dysfunction [J]. Crit Care Med, 2002; 30(3)∶650.
|
4. |
Moncada S, Higgs A. The Largininenitric oxide pathway [J]. N Eng J Med, 1993; 329(27)∶2002.
|
5. |
Thiemermann C .The role of the Larginine: nitric oxide pathway in circulatory shock [J]. Adv Pharmacol, 1994; 28(1)∶45.
|
6. |
Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock [J]. Lancet, 2002; 360(9328)∶219.
|
7. |
Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis [J]. Am J Physiol, 1994; 266(6 Pt 1)∶E829.
|
8. |
Billiar TR, Curran RD, Stuehr DJ, et al. An Largininedependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro [J]. J Exp Med, 1989; 169(4)∶1467.
|
9. |
Nathan C. Nitric oxide as a secretory product of mammalian cells [J]. FASEB J, 1992; 6(12)∶3051.
|